Roivant Sciences Ltd (ROIV)
11.84
-0.04
(-0.34%)
USD |
NASDAQ |
Dec 13, 16:00
11.72
-0.12
(-1.01%)
After-Hours: 20:00
Roivant Sciences Shareholders Equity (Quarterly): 5.153B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Organon & Co | 493.00M |
| AstraZeneca PLC | 40.72B |
| Adaptimmune Therapeutics PLC | 79.99M |
| Biodexa Pharmaceuticals PLC | 11.04M |
| Verona Pharma PLC | 130.49M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.206B |
| Total Liabilities (Quarterly) | 625.99M |
| Current Ratio | 10.43 |
| Net Debt Paydown Yield | 1.02% |